Dividend Equivalents From Sources Within the United States

Official source: Federal Register (GovInfo) (https://www.govinfo.gov/content/pkg/FR-2012-02-06/pdf/C1-2012-1234.pdf), retrieved 2026-10-03. U.S. Government work (17 U.S.C. § 105).

5700 Federal Register / Vol. 77, No. 24 / Monday, February 6, 2012 / Rules and Regulations

DEPARTMENT OF THE TREASURY

Internal Revenue Service

26 CFR Part 1

[TD 9572]

RIN 1545–BK53

Dividend Equivalents From Sources Within the United States

Correction

In rule document 2012–01234 beginning on page 3108 of the issue of Monday, January 23, 2012 make the following correction:

On page 3108, in the second column, in the heading, immediately below ‘‘26 CFR Part 1’’, ‘‘[TD 9572]’’ should appear.

[FR Doc. C1–2012–1234 Filed 2–3–12; 8:45 am]

BILLING CODE 1505–01–D

ENVIRONMENTAL PROTECTION AGENCY

40 CFR Part 52

[EPA–R01–OAR–2011–0346, FRL–9627–8]

Approval and Promulgation of Implementation Plans; New Hampshire: Prevention of Significant Deterioration; Greenhouse Gas Permitting Authority and Tailoring Rule

AGENCY: Environmental Protection Agency (EPA).

ACTION: Final rule.

SUMMARY: EPA is approving revisions to the New Hampshire State Implementation Plan (SIP), submitted by the New Hampshire Department of Environmental Services (NH DES) to EPA on February 7, 2011. The SIP revision modifies New Hampshire’s Prevention of Significant Deterioration (PSD) program to establish appropriate emission thresholds for determining which new stationary sources and modification projects become subject to New Hampshire’s PSD permitting requirements for their greenhouse gas (GHG) emissions. EPA proposed approval of these regulatory revisions on June 14, 2011, and received no comments. This action affects major stationary sources in New Hampshire that have GHG emissions above the thresholds established in the PSD regulations.

DATES: Effective Date: This rule will be effective on March 7, 2012.

ADDRESSES: EPA has established a docket for this action under Docket Identification No. EPA–R01–OAR–

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

21 CFR Parts 510 and 520

[Docket No. FDA–2011–N–0003]

New Animal Drugs; Change of Sponsor; Chlortetracycline Powder

AGENCY: Food and Drug Administration, HHS.

ACTION: Final rule.

SUMMARY: The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect a change of sponsor for an abbreviated new animal drug application (ANADA) for chlortetracycline soluble powder from Teva Animal Health, Inc., to Quo Vademus, LLC.

DATES: This rule is effective February 6, 2012.

FOR FURTHER INFORMATION CONTACT: Steven D. Vaughn, Center for Veterinary Medicine (HFV–100), Food and Drug Administration, 7520 Standish Pl., Rockville, MD 20855, (240) 276–8300, email: steven.vaughn@fda.hhs.gov.

SUPPLEMENTARY INFORMATION: Teva Animal Health, Inc., 3915 South 48th Street Ter., St. Joseph, MO 64503, has informed FDA that it has transferred ownership of, and all rights and interest in, ANADA 200–236 for Chlortetracycline HCL Soluble Powder to Quo Vademus, LLC, 277 Faison McGowan Rd., Kenansville, NC 28349. Accordingly, the Agency is amending the regulations in 21 CFR 520.441 to reflect the transfer of ownership.

Quo Vademus, LLC, is not currently listed in the animal drug regulations as a sponsor of an approved application. Accordingly, 21 CFR 510.600 is being amended to add entries for this sponsor.

This rule does not meet the definition of ‘‘rule’’ in 5 U.S.C. 804(3)(A) because it is a rule of ‘‘particular applicability.’’ Therefore, it is not subject to the congressional review requirements in 5 U.S.C. 801–808.

List of Subjects

21 CFR Part 510

Administrative practice and procedure, Animal drugs, Labeling, Reporting and recordkeeping requirements.

21 CFR Part 520

Animal drugs. Therefore, under the Federal Food, Drug, and Cosmetic Act and under authority delegated to the Commissioner of Food and Drugs and redelegated to

the Center for Veterinary Medicine, 21 CFR parts 510 and 520 are amended as follows:

PART 510—NEW ANIMAL DRUGS

1. The authority citation for 21 CFR part 510 continues to read as follows:

Authority: 21 U.S.C. 321, 331, 351, 352, 353, 360b, 371, 379e.

1. In § 510.600, in the table in paragraph (c)(1), alphabetically add a new entry for ‘‘Quo Vademus, LLC’’; and in the table in paragraph (c)(2), in numerical sequence add a new entry for ‘‘076475’’ to read as follows:

§ 510.600 Names, addresses, and drug labeler codes of sponsors of approved applications.

- - - (c) * - (1) * -

Drug labeler Firm name and address

code

Quo Vademus, LLC, 277

Faison McGowan Rd., Kenansville, NC 28349 ..... 076475

(2) * * *

Drug labeler

Firm name and address code

076475 ........ Quo Vademus, LLC, 277

Faison McGowan Rd., Kenansville, NC 28349

PART 520—ORAL DOSAGE FORM NEW ANIMAL DRUGS

1. The authority citation for 21 CFR part 520 continues to read as follows:

Authority: 21 U.S.C. 360b.

§ 520.441 [Amended]

1. In paragraph (b)(4) of § 520.441, remove ‘‘059130’’ and in its place add ‘‘076475’’.

Dated: February 1, 2012. William T. Flynn, Acting Director, Center for Veterinary Medicine.

[FR Doc. 2012–2633 Filed 2–3–12; 8:45 am]

BILLING CODE 4160–01–P

VerDate Mar<15>2010 20:15 Feb 03, 2012 Jkt 226001 PO 00000 Frm 00020 Fmt 4700 Sfmt 4700 E:\FR\FM\06FER1.SGM 06FER1